DEC 26, 2018 08:13 PM PST

When the Immune System Makes a Mistake: Autoimmunity

A team from Scripps Research has found a molecular cause of a group of rare autoimmune disorders in which the immune system attacks the body's healthy cells.


The discovery, published Dec. 18 in Nature Communications, improves understanding of a protein's role in several autoimmune disorders, including Singleton-Merten syndrome (SMS), Aicardi-Goutières syndrome, familial chilblain lupus, proteasome-associated autoinflammatory syndromes and many others which involve improper stimulation of interferon, says Patrick Griffin, PhD, professor and co-chair of the Department of Molecular Medicine at Scripps Research's Florida campus.


Interferon is a critical component of our frontline defense against pathogens. Interferon earned its name because it interferes with virus' ability to make copies of themselves. The immune system relies on a gene called RIG-I, short for retinoic acid-inducible gene-I, to signal for the release of interferon whenever specific viral markers are encountered. RIG-I has to determine if the markers are of foreign origin or are from its own body. The scientists demonstrated precisely how mistakes in a molecular proofreading system could lead to confusion and generate out-of-control interferon signaling, setting off development of autoimmune disease.


"This dysregulated molecular mechanism of RIG-I mediated RNA proofreading that we identified may help us understand and treat SMS and other autoimmune disorders," says Jie Zheng, Ph.D., a postdoctoral associate and the first author and co-corresponding author of the study.


The National Institutes of Health estimates more than 20 million Americans suffer from autoimmune disorders. They include rheumatoid arthritis, psoriasis, inflammatory bowel disease, multiple sclerosis, lupus, type 1 diabetes, and dozens of others. There are very few safe and effective treatments for such disorders, mainly because so little is understood about how they arise and are sustained.


That is true for SMS, which is so rare that only a few cases have been described in the medical literature. Patients develop serious bone, heart, muscle and skin problems starting in early childhood, primarily due to chronic inflammation from an overactive immune system. The scientists aimed to understand how two RIG-I mutations linked to SMS end up triggering the autoimmunity.


Most viruses have genes made of ribonucleic acid, or RNA, a close chemical cousin of DNA. RIG-I works as an early-warning detector of viral RNA, capable of triggering a broad antiviral immune response, including interferon release. The scientists showed that mutations in RIG-I cause the sensor protein to activate even when it encounters non-viral, "self" RNA. The study aimed to discover the molecular details of how this happens.


RIG-I is a significant protein with flexible elements, and thus is hard to study with standard techniques. But Griffin has helped pioneer the use of an advanced technology called hydrogen-deuterium exchange mass spectrometry (HDX-MS), which enables scientists to analyze the structures and dynamics of just such proteins. For the study, he and his team applied HDX-MS to normal and mutant RIG-I and permanently solved the mystery of how these mutations cause a failure of discrimination between self and viral RNA.


Scientists have known that RIG-I has a particular segment that it keeps mostly covered and concealed. When RIG-I encounters and recognizes viral RNA, this segment is supposed to briefly swing open and thus become available for binding to another protein called MAVS, an event that triggers the immune response. Griffin and colleagues found that the two SMS-linked mutations, in subtly different ways, cause this critical segment of RIG-I to become stuck open -- making it much more likely to bind to MAVS and trigger an immune response.


The scientists now are using their data to try to find a way to target mutant RIG-I, to block its inappropriate signaling to MAVS and thus alleviate the autoimmunity it causes.


This new, detailed understanding of RIG-I's dysfunction may not only provide insights into the origins of more common autoimmune disorders, Griffin says, but it also clarifies how RIG-I usually works to detect viruses, a discovery that may enable development of new antiviral drugs.

Sources: Science Daily, Nature Communications, YouTube

About the Author
You May Also Like
NOV 19, 2019
Health & Medicine
NOV 19, 2019
Toxic Air is Shortening Children's Lifespans
According to the State of Global Air 2019 report, air pollution is currently shortening life expectancy by an average of 20 months worldwide. This means th...
NOV 19, 2019
Plants & Animals
NOV 19, 2019
African Swine Fever a Real Concern as Novel Vaccine Emerges
If you didn’t already know, African swine fever (ASF) is currently ravaging large sums of pigs in the Eastern hemisphere. Wild boars tend to pick up...
NOV 19, 2019
Microbiology
NOV 19, 2019
Healthy Fat From a Beneficial Microbe May Help us Relieve Stress
We may one day be able to use a 'stress vaccine' to ward off the damage caused by traumatic events....
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
The Three Drugs that Reverse Biological Aging
In the last 100 years, life expectancy in the US has risen from 55 years until 79 (Roser: 2019). And with the continuous development of medicine and scie...
NOV 19, 2019
Health & Medicine
NOV 19, 2019
Diagnosis and Treatment of Neurosarcoidosis
Sarcoidosis is a multisystem inflammatory disease characterized by the formation of non-caseating granulomas in the affected organs. The majority of p...
NOV 19, 2019
Immunology
NOV 19, 2019
Allergy Shots May Work for Kids with Pollen Food Allergy Syndrome
It’s not common for young children to develop pollen food allergy syndrome (PFAS), but for those that do, there’s not too much parents can do o...
Loading Comments...